Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Make a choice that matters
The best care starts with the best information
Registration is open for the Division Directors and Program Directors Conference March 8 - 9, 2019.
The ACR’s state advocacy program is advancing rheumatology in your state. The ACR advocates on issues across the country that are affecting patient access and care in the rheumatology community. Advocacy efforts include tracking legislation, providing legislative and regulatory testimony and comments, working with regional coalitions and mobilizing rheumatologists and rheumatology professionals to take an active role in their local legislative process.
The ACR Key Contact Program and local state societies play a critical role in the success of advocacy efforts. You can become a valuable voice in your state by joining your local society or becoming an ACR Key Contact.
Learn more about ACR's advocacy efforts at the state level.
Discover opportunities for advocacy in your area.
See how ACR is working on legislation at the state level.
Find out about state advocacy issues that matter to you and your patients.
Access tools to increase your knowledge and engagement at the state level.
“All politics are local. While there are many national healthcare issues that impact the practice of medicine, strengthening our local and state advocacy efforts is an essential step in protecting our patients' access to their physicians and allied healthcare providers, essential medications, and comprehensive and innovative lab testing, and in helping ensure the viability of our profession. The first step we must take is to build and reinforce local relationships with your state legislators, regional medical directors and allied advocacy groups.“
Howard Blumstein, MDACR Affiliate Society Council
Thank you for your interest in getting involved with rheumatology advocacy Please fill out the form below and your information will be sent to ACR staff.